Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer

Background Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases. Meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 2021-08, Vol.50 (4), p.1325-1334
Hauptverfasser: Besson, Caroline, Moore, Amy, Wu, Wenting, Vajdic, Claire M, de Sanjose, Silvia, Camp, Nicola J, Smedby, Karin E, Shanafelt, Tait D, Morton, Lindsay M, Brewer, Jerry D, Zablotska, Lydia, Engels, Eric A, Cerhan, James R, Slager, Susan L, Han, Jiali, Berndt, Sonja I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1334
container_issue 4
container_start_page 1325
container_title INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
container_volume 50
creator Besson, Caroline
Moore, Amy
Wu, Wenting
Vajdic, Claire M
de Sanjose, Silvia
Camp, Nicola J
Smedby, Karin E
Shanafelt, Tait D
Morton, Lindsay M
Brewer, Jerry D
Zablotska, Lydia
Engels, Eric A
Cerhan, James R
Slager, Susan L
Han, Jiali
Berndt, Sonja I
description Background Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases. Methods We examined the association between (i) established NMSC susceptibility loci and CLL risk in a meta-analysis including 3100 CLL cases and 7667 controls and (ii) established CLL loci and NMSC risk in a study of 4242 basal cell carcinoma (BCC) cases, 825 squamous cell carcinoma (SCC) cases and 12802 controls. Polygenic risk scores (PRS) for CLL, BCC and SCC were constructed using established loci. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results Higher CLL-PRS was associated with increased BCC risk (OR4th-quartile-vs-1st-quartile = 1.13, 95% CI: 1.02–1.24, Ptrend = 0.009), even after removing the shared 6p25.3 locus. No association was observed with BCC-PRS and CLL risk (Ptrend = 0.68). These findings support a contributory role for CLL in BCC risk, but not for BCC in CLL risk. Increased CLL risk was observed with higher SCC-PRS (OR4th-quartile-vs-1st-quartile = 1.22, 95% CI: 1.08–1.38, Ptrend = 1.36 × 10–5), which was driven by shared genetic susceptibility at the 6p25.3 locus. Conclusion These findings highlight the role of pleiotropy regarding the pathogenesis of CLL and NMSC and shows that a single pleiotropic locus, 6p25.3, drives the observed association between genetic susceptibility to SCC and increased CLL risk. The study also provides evidence that genetic susceptibility for CLL increases BCC risk.
doi_str_mv 10.1093/ije/dyab042
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_463410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ije/dyab042</oup_id><sourcerecordid>2503675977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-2137b17518ffea8d0f2e70a62ba96663c2eb26218a7c87c39345c3c701bb56f23</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxS0EotvCiTvyCSGhUH87uSChFRSkSlzgbNneSeNubIc4odoD_zuudqnohZNHnt97M5qH0CtK3lPS8ctwC5e7g3VEsCdoQ4USDVetfIo2hBPSSK3pGTov5ZYQKoTonqMzzrVoWy436Pc2x5gTvoEES_B4yuMh5nkaQokF-5yWObh1AbxkvAyAbSnZB7uEqnGw3AEk7Ic5p6qtymnI_nDvM8K6txCDxTbtcMqpiTDalKPFZR-qxiYP8wv0rLdjgZen9wL9-Pzp-_ZLc_3t6uv243XjhSRLwyjXjmpJ274H2-5Iz0ATq5iznVKKewaOKUZbq32rPe-4kJ57TahzUvWMX6Dm6FvuYFqdmeYQ7Xww2QZz-trXCoxQXFBS-Q9HvnYi7DzUM9jxkexxJ4XB3ORfppV1Cy2rwduTwZx_rlAWE0PxMNYTQF6LYZJwpWWndUXfHVE_51Jm6B_GUGLuAzY1YHMKuNKv_93sgf2baAXeHIG8Tv91-gNCfrRQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2503675977</pqid></control><display><type>article</type><title>Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><creator>Besson, Caroline ; Moore, Amy ; Wu, Wenting ; Vajdic, Claire M ; de Sanjose, Silvia ; Camp, Nicola J ; Smedby, Karin E ; Shanafelt, Tait D ; Morton, Lindsay M ; Brewer, Jerry D ; Zablotska, Lydia ; Engels, Eric A ; Cerhan, James R ; Slager, Susan L ; Han, Jiali ; Berndt, Sonja I</creator><creatorcontrib>Besson, Caroline ; Moore, Amy ; Wu, Wenting ; Vajdic, Claire M ; de Sanjose, Silvia ; Camp, Nicola J ; Smedby, Karin E ; Shanafelt, Tait D ; Morton, Lindsay M ; Brewer, Jerry D ; Zablotska, Lydia ; Engels, Eric A ; Cerhan, James R ; Slager, Susan L ; Han, Jiali ; Berndt, Sonja I ; InterLymph Consortium. Full authors list is given at the end of the manuscript ; the InterLymph Consortium. Full authors list is given at the end of the manuscript</creatorcontrib><description>Background Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases. Methods We examined the association between (i) established NMSC susceptibility loci and CLL risk in a meta-analysis including 3100 CLL cases and 7667 controls and (ii) established CLL loci and NMSC risk in a study of 4242 basal cell carcinoma (BCC) cases, 825 squamous cell carcinoma (SCC) cases and 12802 controls. Polygenic risk scores (PRS) for CLL, BCC and SCC were constructed using established loci. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results Higher CLL-PRS was associated with increased BCC risk (OR4th-quartile-vs-1st-quartile = 1.13, 95% CI: 1.02–1.24, Ptrend = 0.009), even after removing the shared 6p25.3 locus. No association was observed with BCC-PRS and CLL risk (Ptrend = 0.68). These findings support a contributory role for CLL in BCC risk, but not for BCC in CLL risk. Increased CLL risk was observed with higher SCC-PRS (OR4th-quartile-vs-1st-quartile = 1.22, 95% CI: 1.08–1.38, Ptrend = 1.36 × 10–5), which was driven by shared genetic susceptibility at the 6p25.3 locus. Conclusion These findings highlight the role of pleiotropy regarding the pathogenesis of CLL and NMSC and shows that a single pleiotropic locus, 6p25.3, drives the observed association between genetic susceptibility to SCC and increased CLL risk. The study also provides evidence that genetic susceptibility for CLL increases BCC risk.</description><identifier>ISSN: 0300-5771</identifier><identifier>EISSN: 1464-3685</identifier><identifier>DOI: 10.1093/ije/dyab042</identifier><identifier>PMID: 33748835</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Carcinoma, Basal Cell - epidemiology ; Carcinoma, Basal Cell - genetics ; Carcinoma, Squamous Cell - epidemiology ; Carcinoma, Squamous Cell - genetics ; Genetics ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology ; Leukemia, Lymphocytic, Chronic, B-Cell - genetics ; Polymorphism, Single Nucleotide ; Risk Factors ; Skin Neoplasms - epidemiology ; Skin Neoplasms - genetics</subject><ispartof>INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021-08, Vol.50 (4), p.1325-1334</ispartof><rights>Published by Oxford University Press on behalf of the International Epidemiological Association 2021. This work is written by US Government employees and is in the public domain in the US. 2021</rights><rights>Published by Oxford University Press on behalf of the International Epidemiological Association 2021. This work is written by US Government employees and is in the public domain in the US.</rights><rights>Published by Oxford University Press on behalf of the International Epidemiological Association 2021. This work is written by US Government employees and is in the public domain in the US. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-2137b17518ffea8d0f2e70a62ba96663c2eb26218a7c87c39345c3c701bb56f23</citedby><cites>FETCH-LOGICAL-c450t-2137b17518ffea8d0f2e70a62ba96663c2eb26218a7c87c39345c3c701bb56f23</cites><orcidid>0000-0002-7482-178X ; 0000-0002-8309-7092 ; 0000-0003-4364-7173</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33748835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:147884622$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Besson, Caroline</creatorcontrib><creatorcontrib>Moore, Amy</creatorcontrib><creatorcontrib>Wu, Wenting</creatorcontrib><creatorcontrib>Vajdic, Claire M</creatorcontrib><creatorcontrib>de Sanjose, Silvia</creatorcontrib><creatorcontrib>Camp, Nicola J</creatorcontrib><creatorcontrib>Smedby, Karin E</creatorcontrib><creatorcontrib>Shanafelt, Tait D</creatorcontrib><creatorcontrib>Morton, Lindsay M</creatorcontrib><creatorcontrib>Brewer, Jerry D</creatorcontrib><creatorcontrib>Zablotska, Lydia</creatorcontrib><creatorcontrib>Engels, Eric A</creatorcontrib><creatorcontrib>Cerhan, James R</creatorcontrib><creatorcontrib>Slager, Susan L</creatorcontrib><creatorcontrib>Han, Jiali</creatorcontrib><creatorcontrib>Berndt, Sonja I</creatorcontrib><creatorcontrib>InterLymph Consortium. Full authors list is given at the end of the manuscript</creatorcontrib><creatorcontrib>the InterLymph Consortium. Full authors list is given at the end of the manuscript</creatorcontrib><title>Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer</title><title>INTERNATIONAL JOURNAL OF EPIDEMIOLOGY</title><addtitle>Int J Epidemiol</addtitle><description>Background Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases. Methods We examined the association between (i) established NMSC susceptibility loci and CLL risk in a meta-analysis including 3100 CLL cases and 7667 controls and (ii) established CLL loci and NMSC risk in a study of 4242 basal cell carcinoma (BCC) cases, 825 squamous cell carcinoma (SCC) cases and 12802 controls. Polygenic risk scores (PRS) for CLL, BCC and SCC were constructed using established loci. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results Higher CLL-PRS was associated with increased BCC risk (OR4th-quartile-vs-1st-quartile = 1.13, 95% CI: 1.02–1.24, Ptrend = 0.009), even after removing the shared 6p25.3 locus. No association was observed with BCC-PRS and CLL risk (Ptrend = 0.68). These findings support a contributory role for CLL in BCC risk, but not for BCC in CLL risk. Increased CLL risk was observed with higher SCC-PRS (OR4th-quartile-vs-1st-quartile = 1.22, 95% CI: 1.08–1.38, Ptrend = 1.36 × 10–5), which was driven by shared genetic susceptibility at the 6p25.3 locus. Conclusion These findings highlight the role of pleiotropy regarding the pathogenesis of CLL and NMSC and shows that a single pleiotropic locus, 6p25.3, drives the observed association between genetic susceptibility to SCC and increased CLL risk. The study also provides evidence that genetic susceptibility for CLL increases BCC risk.</description><subject>Carcinoma, Basal Cell - epidemiology</subject><subject>Carcinoma, Basal Cell - genetics</subject><subject>Carcinoma, Squamous Cell - epidemiology</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Genetics</subject><subject>Humans</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - genetics</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Risk Factors</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - genetics</subject><issn>0300-5771</issn><issn>1464-3685</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp9kc1v1DAQxS0EotvCiTvyCSGhUH87uSChFRSkSlzgbNneSeNubIc4odoD_zuudqnohZNHnt97M5qH0CtK3lPS8ctwC5e7g3VEsCdoQ4USDVetfIo2hBPSSK3pGTov5ZYQKoTonqMzzrVoWy436Pc2x5gTvoEES_B4yuMh5nkaQokF-5yWObh1AbxkvAyAbSnZB7uEqnGw3AEk7Ic5p6qtymnI_nDvM8K6txCDxTbtcMqpiTDalKPFZR-qxiYP8wv0rLdjgZen9wL9-Pzp-_ZLc_3t6uv243XjhSRLwyjXjmpJ274H2-5Iz0ATq5iznVKKewaOKUZbq32rPe-4kJ57TahzUvWMX6Dm6FvuYFqdmeYQ7Xww2QZz-trXCoxQXFBS-Q9HvnYi7DzUM9jxkexxJ4XB3ORfppV1Cy2rwduTwZx_rlAWE0PxMNYTQF6LYZJwpWWndUXfHVE_51Jm6B_GUGLuAzY1YHMKuNKv_93sgf2baAXeHIG8Tv91-gNCfrRQ</recordid><startdate>20210830</startdate><enddate>20210830</enddate><creator>Besson, Caroline</creator><creator>Moore, Amy</creator><creator>Wu, Wenting</creator><creator>Vajdic, Claire M</creator><creator>de Sanjose, Silvia</creator><creator>Camp, Nicola J</creator><creator>Smedby, Karin E</creator><creator>Shanafelt, Tait D</creator><creator>Morton, Lindsay M</creator><creator>Brewer, Jerry D</creator><creator>Zablotska, Lydia</creator><creator>Engels, Eric A</creator><creator>Cerhan, James R</creator><creator>Slager, Susan L</creator><creator>Han, Jiali</creator><creator>Berndt, Sonja I</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-7482-178X</orcidid><orcidid>https://orcid.org/0000-0002-8309-7092</orcidid><orcidid>https://orcid.org/0000-0003-4364-7173</orcidid></search><sort><creationdate>20210830</creationdate><title>Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer</title><author>Besson, Caroline ; Moore, Amy ; Wu, Wenting ; Vajdic, Claire M ; de Sanjose, Silvia ; Camp, Nicola J ; Smedby, Karin E ; Shanafelt, Tait D ; Morton, Lindsay M ; Brewer, Jerry D ; Zablotska, Lydia ; Engels, Eric A ; Cerhan, James R ; Slager, Susan L ; Han, Jiali ; Berndt, Sonja I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-2137b17518ffea8d0f2e70a62ba96663c2eb26218a7c87c39345c3c701bb56f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Carcinoma, Basal Cell - epidemiology</topic><topic>Carcinoma, Basal Cell - genetics</topic><topic>Carcinoma, Squamous Cell - epidemiology</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Genetics</topic><topic>Humans</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - genetics</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Risk Factors</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Besson, Caroline</creatorcontrib><creatorcontrib>Moore, Amy</creatorcontrib><creatorcontrib>Wu, Wenting</creatorcontrib><creatorcontrib>Vajdic, Claire M</creatorcontrib><creatorcontrib>de Sanjose, Silvia</creatorcontrib><creatorcontrib>Camp, Nicola J</creatorcontrib><creatorcontrib>Smedby, Karin E</creatorcontrib><creatorcontrib>Shanafelt, Tait D</creatorcontrib><creatorcontrib>Morton, Lindsay M</creatorcontrib><creatorcontrib>Brewer, Jerry D</creatorcontrib><creatorcontrib>Zablotska, Lydia</creatorcontrib><creatorcontrib>Engels, Eric A</creatorcontrib><creatorcontrib>Cerhan, James R</creatorcontrib><creatorcontrib>Slager, Susan L</creatorcontrib><creatorcontrib>Han, Jiali</creatorcontrib><creatorcontrib>Berndt, Sonja I</creatorcontrib><creatorcontrib>InterLymph Consortium. Full authors list is given at the end of the manuscript</creatorcontrib><creatorcontrib>the InterLymph Consortium. Full authors list is given at the end of the manuscript</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>INTERNATIONAL JOURNAL OF EPIDEMIOLOGY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Besson, Caroline</au><au>Moore, Amy</au><au>Wu, Wenting</au><au>Vajdic, Claire M</au><au>de Sanjose, Silvia</au><au>Camp, Nicola J</au><au>Smedby, Karin E</au><au>Shanafelt, Tait D</au><au>Morton, Lindsay M</au><au>Brewer, Jerry D</au><au>Zablotska, Lydia</au><au>Engels, Eric A</au><au>Cerhan, James R</au><au>Slager, Susan L</au><au>Han, Jiali</au><au>Berndt, Sonja I</au><aucorp>InterLymph Consortium. Full authors list is given at the end of the manuscript</aucorp><aucorp>the InterLymph Consortium. Full authors list is given at the end of the manuscript</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer</atitle><jtitle>INTERNATIONAL JOURNAL OF EPIDEMIOLOGY</jtitle><addtitle>Int J Epidemiol</addtitle><date>2021-08-30</date><risdate>2021</risdate><volume>50</volume><issue>4</issue><spage>1325</spage><epage>1334</epage><pages>1325-1334</pages><issn>0300-5771</issn><eissn>1464-3685</eissn><abstract>Background Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases. Methods We examined the association between (i) established NMSC susceptibility loci and CLL risk in a meta-analysis including 3100 CLL cases and 7667 controls and (ii) established CLL loci and NMSC risk in a study of 4242 basal cell carcinoma (BCC) cases, 825 squamous cell carcinoma (SCC) cases and 12802 controls. Polygenic risk scores (PRS) for CLL, BCC and SCC were constructed using established loci. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results Higher CLL-PRS was associated with increased BCC risk (OR4th-quartile-vs-1st-quartile = 1.13, 95% CI: 1.02–1.24, Ptrend = 0.009), even after removing the shared 6p25.3 locus. No association was observed with BCC-PRS and CLL risk (Ptrend = 0.68). These findings support a contributory role for CLL in BCC risk, but not for BCC in CLL risk. Increased CLL risk was observed with higher SCC-PRS (OR4th-quartile-vs-1st-quartile = 1.22, 95% CI: 1.08–1.38, Ptrend = 1.36 × 10–5), which was driven by shared genetic susceptibility at the 6p25.3 locus. Conclusion These findings highlight the role of pleiotropy regarding the pathogenesis of CLL and NMSC and shows that a single pleiotropic locus, 6p25.3, drives the observed association between genetic susceptibility to SCC and increased CLL risk. The study also provides evidence that genetic susceptibility for CLL increases BCC risk.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>33748835</pmid><doi>10.1093/ije/dyab042</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7482-178X</orcidid><orcidid>https://orcid.org/0000-0002-8309-7092</orcidid><orcidid>https://orcid.org/0000-0003-4364-7173</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-5771
ispartof INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021-08, Vol.50 (4), p.1325-1334
issn 0300-5771
1464-3685
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_463410
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; SWEPUB Freely available online
subjects Carcinoma, Basal Cell - epidemiology
Carcinoma, Basal Cell - genetics
Carcinoma, Squamous Cell - epidemiology
Carcinoma, Squamous Cell - genetics
Genetics
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology
Leukemia, Lymphocytic, Chronic, B-Cell - genetics
Polymorphism, Single Nucleotide
Risk Factors
Skin Neoplasms - epidemiology
Skin Neoplasms - genetics
title Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A12%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Common%20genetic%20polymorphisms%20contribute%20to%20the%20association%20between%20chronic%20lymphocytic%20leukaemia%20and%20non-melanoma%20skin%20cancer&rft.jtitle=INTERNATIONAL%20JOURNAL%20OF%20EPIDEMIOLOGY&rft.au=Besson,%20Caroline&rft.aucorp=InterLymph%20Consortium.%20Full%20authors%20list%20is%20given%20at%20the%20end%20of%20the%20manuscript&rft.date=2021-08-30&rft.volume=50&rft.issue=4&rft.spage=1325&rft.epage=1334&rft.pages=1325-1334&rft.issn=0300-5771&rft.eissn=1464-3685&rft_id=info:doi/10.1093/ije/dyab042&rft_dat=%3Cproquest_swepu%3E2503675977%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2503675977&rft_id=info:pmid/33748835&rft_oup_id=10.1093/ije/dyab042&rfr_iscdi=true